Chinese
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Overview of attention for article published in The Lancet, August 2021
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (99th percentile)
-
High Attention Score compared to outputs of the same age and source (96th percentile)
Mentioned by
- news
- 74 news outlets
- blogs
- 9 blogs
- policy
- 2 policy sources
- 2332 X users
- patent
- 7 patents
- 5 Facebook pages
- wikipedia
- 2 Wikipedia pages
- 7 Redditors
- guideline
- 3 clinical guideline sources
- bluesky
- 2 Bluesky users
- podcasts
- 1 podcast
Readers on
- mendeley
- 366 Mendeley